Tau in cerebrospinal fluid: A potential diagnostic marker in Alzheimer's disease-Reference-Cited by-同舟云学术

Tau in cerebrospinal fluid: A potential diagnostic marker in Alzheimer's disease

Published:1995-10 Issue:4 Volume:38 Page:649-652
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Arai Hiroyuki,Terajima Masanori,Miura Masakazu,Higuchi Susumu,Muramatsu Taro,Machida Nobuo,Seiki Hisatomo,Takase Sadao,Clark Christopher M.,Lee Virginia M.-Y.,Trojanowski John Q.,Sasaki Hidetada

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference17 articles.

1. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

2. Diagnosis of Alzheimer's Disease

3. Amyloid ? protein levels in cerebrospinal fluid are elevated in early-onset Alzheimer's disease

4. Decreased levels of soluble amyloid beta-protein precursor in cerebrospinal fluid of live Alzheimer disease patients.

5. Alzheimer's disease: paired helical filament immunoreactivity in cerebrospinal fluid

Cited by 265 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cellular and pathological functions of tau;Nature Reviews Molecular Cell Biology;2024-07-16

2. Tau, Glial Fibrillary Acidic Protein, and Neurofilament Light Chain as Brain Protein Biomarkers in Cerebrospinal Fluid and Blood for Diagnosis of Neurobiological Diseases;International Journal of Molecular Sciences;2024-06-07

3. Tau: a biomarker of Huntington’s disease;Molecular Psychiatry;2023-09-25

4. Advanced Overview of Biomarkers and Techniques for Early Diagnosis of Alzheimer’s Disease;Cellular and Molecular Neurobiology;2023-02-27

5. Neuroprotective Effects of Vapreotide on Tau Transfection–Induced Neurodegeneration;Neurotoxicity Research;2022-11-15